GMRE
GMRE
Global Medical REIT Inc.Income Statement
| Period | Revenue | Operating Expense | Net Income | Net Profit Margin | Earnings Per Share | EBITDA |
|---|---|---|---|---|---|---|
| Q4-2025 | $35.17M ▼ | $38.39M ▲ | $-11.78M ▼ | -33.5% ▼ | $-0.55 ▼ | $984K ▼ |
| Q3-2025 | $40.56M ▲ | $4.86M ▼ | $-4.55M ▼ | -11.21% ▼ | $-0.45 ▼ | $9.95M ▼ |
| Q2-2025 | $37.88M ▲ | $21.32M ▲ | $655K ▼ | 1.73% ▼ | $-0.3 ▼ | $23.89M ▼ |
| Q1-2025 | $34.59M ▼ | $17.45M ▼ | $3.56M ▲ | 10.29% ▲ | $0.79 ▲ | $24.95M ▲ |
| Q4-2024 | $34.95M | $21.35M | $2.83M | 8.1% | $0.52 | $24.4M |
Balance Statement
| Period | Cash & Short-term | Total Assets | Total Liabilities | Total Equity |
|---|---|---|---|---|
| Q4-2025 | $9.08M ▲ | $1.24B ▼ | $712.4M ▼ | $509.77M ▲ |
| Q3-2025 | $7.12M ▲ | $1.27B ▼ | $767.41M ▼ | $485.29M ▼ |
| Q2-2025 | $6.58M ▲ | $1.3B ▲ | $771.94M ▲ | $503.2M ▼ |
| Q1-2025 | $5.41M ▼ | $1.27B ▲ | $731.45M ▲ | $517.35M ▼ |
| Q4-2024 | $6.82M | $1.26B | $700.57M | $534.13M |
Cash Flow Statement
| Period | Net Income | Cash From Operations | Cash From Investing | Cash From Financing | Net Change | Free Cash Flow |
|---|---|---|---|---|---|---|
| Q3-2025 | $-5.06M ▼ | $17.57M ▼ | $-703K ▲ | $-16.25M ▼ | $614K ▼ | $92.61M ▲ |
| Q2-2025 | $585K ▼ | $22.14M ▲ | $-39.23M ▼ | $18.72M ▲ | $1.64M ▲ | $-18.32M ▲ |
| Q1-2025 | $3.56M ▲ | $12.27M ▼ | $-27.22M ▼ | $13.6M ▲ | $-1.35M ▼ | $-22.32M ▲ |
| Q4-2024 | $2.94M ▼ | $20.52M ▲ | $-19.52M ▲ | $153K ▼ | $1.15M ▲ | $-33.34M ▼ |
| Q3-2024 | $3.2M | $16.3M | $-25.49M | $9.16M | $-29K | $21.51M |
What's strong about this company's cash flow?
The company generated a large amount of free cash flow this quarter, easily covering dividends and allowing it to pay down debt. Cash flow quality is high, with real cash coming in even though net income was negative.
What are the cash flow concerns?
Operating cash flow fell compared to last quarter, and the cash balance is still modest. The big swing in free cash flow may not be repeated if capital spending rises again.
Q3 2025 Earnings Call Summary
Read Call Summary5-Year Trend Analysis
A comprehensive look at Global Medical REIT Inc.'s financial evolution and strategic trajectory over the past five years.
Key strengths include a focused portfolio of healthcare properties supported by long-term, largely triple‑net leases and high occupancy, which together provide a relatively resilient rental income stream. The company has demonstrated strong cash generation from operations despite accounting losses, and it controls a sizable asset base that anchors its valuation. Management’s sector expertise, willingness to operate in less crowded markets, and openness to adjacent growth avenues such as active adult housing also support the long-term strategic narrative. Short-term liquidity appears adequate, and the absence of near-term debt maturities, as described in recent communications, reduces immediate refinancing risk.
Main risks center on profitability, leverage dynamics, and tenant health. Accounting losses and negative retained earnings highlight that, under current structures, interest expense and overhead weigh heavily on earnings. Free cash flow is negative once growth investments are included, while dividends remain substantial, implying dependence on capital markets to bridge the gap. Tenant concentration and the credit quality of healthcare operators—illustrated by the bankruptcy of a hospital tenant—create property-level cash flow risk. The business model is also sensitive to interest rate movements and healthcare policy changes, both of which can affect valuations, borrowing costs, and tenant viability. A sizable intangible asset component adds potential for future write-downs if performance disappoints.
Taken together, GMRE (now Chiron Real Estate) appears to be in a transition phase: operationally underpinned by a stable healthcare-focused property portfolio, yet financially challenged by the balance between growth ambitions, payout levels, and financing costs. If management can continue to grow and optimize the portfolio, maintain high occupancy, and gradually align investment pace and dividends with internally generated cash, the underlying cash-flow profile could strengthen over time. Conversely, a prolonged period of high interest rates, tenant stress, or weaker access to capital could constrain growth and pressure distributions. The forward picture is therefore balanced—supported by a defensible niche and strategic evolution, but contingent on disciplined execution and a cooperative macro and sector backdrop.
About Global Medical REIT Inc.
https://www.globalmedicalreit.comGlobal Medical REIT Inc. is net-lease medical office REIT that acquires purpose-built specialized healthcare facilities and leases those facilities to strong healthcare systems and physician groups with leading market share.
Income Statement
| Period | Revenue | Operating Expense | Net Income | Net Profit Margin | Earnings Per Share | EBITDA |
|---|---|---|---|---|---|---|
| Q4-2025 | $35.17M ▼ | $38.39M ▲ | $-11.78M ▼ | -33.5% ▼ | $-0.55 ▼ | $984K ▼ |
| Q3-2025 | $40.56M ▲ | $4.86M ▼ | $-4.55M ▼ | -11.21% ▼ | $-0.45 ▼ | $9.95M ▼ |
| Q2-2025 | $37.88M ▲ | $21.32M ▲ | $655K ▼ | 1.73% ▼ | $-0.3 ▼ | $23.89M ▼ |
| Q1-2025 | $34.59M ▼ | $17.45M ▼ | $3.56M ▲ | 10.29% ▲ | $0.79 ▲ | $24.95M ▲ |
| Q4-2024 | $34.95M | $21.35M | $2.83M | 8.1% | $0.52 | $24.4M |
Balance Statement
| Period | Cash & Short-term | Total Assets | Total Liabilities | Total Equity |
|---|---|---|---|---|
| Q4-2025 | $9.08M ▲ | $1.24B ▼ | $712.4M ▼ | $509.77M ▲ |
| Q3-2025 | $7.12M ▲ | $1.27B ▼ | $767.41M ▼ | $485.29M ▼ |
| Q2-2025 | $6.58M ▲ | $1.3B ▲ | $771.94M ▲ | $503.2M ▼ |
| Q1-2025 | $5.41M ▼ | $1.27B ▲ | $731.45M ▲ | $517.35M ▼ |
| Q4-2024 | $6.82M | $1.26B | $700.57M | $534.13M |
Cash Flow Statement
| Period | Net Income | Cash From Operations | Cash From Investing | Cash From Financing | Net Change | Free Cash Flow |
|---|---|---|---|---|---|---|
| Q3-2025 | $-5.06M ▼ | $17.57M ▼ | $-703K ▲ | $-16.25M ▼ | $614K ▼ | $92.61M ▲ |
| Q2-2025 | $585K ▼ | $22.14M ▲ | $-39.23M ▼ | $18.72M ▲ | $1.64M ▲ | $-18.32M ▲ |
| Q1-2025 | $3.56M ▲ | $12.27M ▼ | $-27.22M ▼ | $13.6M ▲ | $-1.35M ▼ | $-22.32M ▲ |
| Q4-2024 | $2.94M ▼ | $20.52M ▲ | $-19.52M ▲ | $153K ▼ | $1.15M ▲ | $-33.34M ▼ |
| Q3-2024 | $3.2M | $16.3M | $-25.49M | $9.16M | $-29K | $21.51M |
What's strong about this company's cash flow?
The company generated a large amount of free cash flow this quarter, easily covering dividends and allowing it to pay down debt. Cash flow quality is high, with real cash coming in even though net income was negative.
What are the cash flow concerns?
Operating cash flow fell compared to last quarter, and the cash balance is still modest. The big swing in free cash flow may not be repeated if capital spending rises again.
Q3 2025 Earnings Call Summary
Read Call Summary5-Year Trend Analysis
A comprehensive look at Global Medical REIT Inc.'s financial evolution and strategic trajectory over the past five years.
Key strengths include a focused portfolio of healthcare properties supported by long-term, largely triple‑net leases and high occupancy, which together provide a relatively resilient rental income stream. The company has demonstrated strong cash generation from operations despite accounting losses, and it controls a sizable asset base that anchors its valuation. Management’s sector expertise, willingness to operate in less crowded markets, and openness to adjacent growth avenues such as active adult housing also support the long-term strategic narrative. Short-term liquidity appears adequate, and the absence of near-term debt maturities, as described in recent communications, reduces immediate refinancing risk.
Main risks center on profitability, leverage dynamics, and tenant health. Accounting losses and negative retained earnings highlight that, under current structures, interest expense and overhead weigh heavily on earnings. Free cash flow is negative once growth investments are included, while dividends remain substantial, implying dependence on capital markets to bridge the gap. Tenant concentration and the credit quality of healthcare operators—illustrated by the bankruptcy of a hospital tenant—create property-level cash flow risk. The business model is also sensitive to interest rate movements and healthcare policy changes, both of which can affect valuations, borrowing costs, and tenant viability. A sizable intangible asset component adds potential for future write-downs if performance disappoints.
Taken together, GMRE (now Chiron Real Estate) appears to be in a transition phase: operationally underpinned by a stable healthcare-focused property portfolio, yet financially challenged by the balance between growth ambitions, payout levels, and financing costs. If management can continue to grow and optimize the portfolio, maintain high occupancy, and gradually align investment pace and dividends with internally generated cash, the underlying cash-flow profile could strengthen over time. Conversely, a prolonged period of high interest rates, tenant stress, or weaker access to capital could constrain growth and pressure distributions. The forward picture is therefore balanced—supported by a defensible niche and strategic evolution, but contingent on disciplined execution and a cooperative macro and sector backdrop.

CEO
Mark O. Decker Jr.
Compensation Summary
(Year 2020)
Upcoming Earnings
Split Record
| Date | Type | Ratio |
|---|---|---|
| 2025-09-22 | Reverse | 1:5 |
ETFs Holding This Stock
Summary
Showing Top 3 of 44
Most Recent Analyst Grades
Grade Summary
Showing Top 3 of 3
Price Target
Institutional Ownership
BLACKROCK INC.
Shares:5.26M
Value:$195.59M
VANGUARD GROUP INC
Shares:1.28M
Value:$47.67M
BLACKROCK, INC.
Shares:1.17M
Value:$43.44M
Summary
Showing Top 3 of 241

